# Proof-of-concept (PoC) Study of APD515

> **NCT01331746** · PHASE2 · COMPLETED · sponsor: **Acacia Pharma Ltd** · enrollment: 32 (actual)

## Conditions studied

- Xerostomia in Advanced Cancer Patients

## Interventions

- **DRUG:** APD515
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01331746
- **Lead sponsor:** Acacia Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331746, "Proof-of-concept (PoC) Study of APD515". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01331746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*